GSK Korea General Manager Maurizio Borgatta / Courtesy of GSK Korea
By Sah Dong-suk
GSK, a global biopharmaceutical company that aims to combine science, technology and talent to conquer diseases, is dedicated to preventing and treating them with specialty drugs, vaccines and general drugs in four core therapeutic areas: infectious diseases, oncology, HIV and respiratory, immunology and inflammation.
For nearly 40 years, GSK has contributed to the improvement of health care in Korea, trying to address the unmet needs of patients and public health by developing innovative medicines and vaccines.
With a strong ambition to help patients, GSK Korea is confident of delivering a positive health impact by preventing and treating diseases, helping to protect people and supporting health care systems.
GSK’s culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how it delivers for patients together.
The company has also embedded a growth mindset in the organization to create an environment where people can develop, feel supported and succeed in the face of challenges. In recognition of these efforts, GSK Korea was certified as a Great Place to Work in 2024.
Maurizio Borgatta, general manager of GSK Korea, emphasizes the importance of building a great place to work to accomplish the company’s purpose.
Borgatta said, “Inclusive leadership is an integral part of making everyone feel valued and respected and ultimately enabling better performance. With these efforts, I am confident that we can continue and even expand our commitment to positively impact the health of Koreans with our innovative treatments and vaccines."
English (United States) ·